申请人:Merck & Co., Inc.
公开号:US04782080A1
公开(公告)日:1988-11-01
N-Alkenyl-2-hydroxybenzo[b]thiophene-3-carboxamide derivatives are prepared via treatment of the corresponding unsubstituted carboxamide with appropriate agents, such as aldehydes, ketones, enol ethers, epoxides, acetals or ketals. These compounds have been found to be effective inhibitors of both cyclooxygenase and lipoxygenase and thereby useful in the treatment of pain, fever, inflammation, arthritic conditions, asthma, allergic disorders, skin diseases, cardiovascular disorders, psoriasis, inflammatory bowel disease, glaucoma or other prostaglandins and/or leukotriene mediated diseases.
通过将相应的未取代的羧酰胺与适当的试剂(如醛、酮、烯醚、环氧化物、缩醛或缩酮)处理,制备N-烯基-2-羟基苯并[b]噻吩-3-羧酰胺衍生物。这些化合物已被发现是环氧合酶和脂氧合酶的有效抑制剂,因此在治疗疼痛、发热、炎症、关节炎、哮喘、过敏性疾病、皮肤病、心血管疾病、银屑病、炎症性肠病、青光眼或其他前列腺素和/或白三烯介导的疾病中有用。